What are the top competitors of Bristol-Myers Squibb Company in Healthcare sector?

The top competitors of Bristol-Myers Squibb Company in the Healthcare sector are: Biogen Inc. (BIIB.SW), DocMorris AG (ROSE.SW), DocMorris AG (DOCM.SW), Johnson & Johnson (JNJ.SW).

Which has better valuations & earnings, Bristol-Myers Squibb Company or its competitors?

Bristol-Myers Squibb Company has a market cap of 70.7B and a Dividend Yield of 3.50% compared to its competitors.

Which stock is more profitable: Bristol-Myers Squibb Company or its competitors?

Bristol-Myers Squibb Company has an EPS of CHF2.69, while BIIB.SW has an EPS of CHF6.80. So, Bristol-Myers Squibb Company is more profitable compared to BIIB.SW.

What is Bristol-Myers Squibb Company stock volatility and risk in terms of investment?

Bristol-Myers Squibb Company has daily volatility of 0% as compared to its competitor BIIB.SW which is 0%. Bristol-Myers Squibb Company is less volatile as compared to competitors and has low risk.

Is Bristol-Myers Squibb Company stock profitable?

Bristol-Myers Squibb Company has a Return on Equity (ROE) of 0.37%. So, Bristol-Myers Squibb Company is more profitable.

What is Bristol-Myers Squibb Company stock’s 52 weeks high and low?

Bristol-Myers Squibb Company stock has a 52-week high of (CHF44.75) and a low of (CHF42.54).

What was the average volume of Bristol-Myers Squibb Company stock?

The average volume of Bristol-Myers Squibb Company is (22) in terms of investment.

Bristol-Myers Squibb Company (BMY.SW) Competitors

Bristol-Myers Squibb Company (BMY.SW) Stock Competitors & Peer Comparison

See (BMY.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
BMY.SW	CHF 42.54	-4.40%	70.7B	15.81	CHF 2.69	+3.50%
BIIB.SW	CHF 147.46	-36.44%	21.6B	21.69	CHF 6.80	N/A
ROSE.SW	CHF 35.02	N/A	404.5M	-2.28	-CHF 15.35	N/A
DOCM.SW	CHF 4.74	-1.25%	230.5M	-1.04	-CHF 4.58	N/A
JNJ.SW	CHF 193.57	+4.86%	0	N/A	N/A	+0.52%

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BMY.SW vs BIIB.SW Comparison March 2026

BMY.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BMY.SW stands at 70.7B. In comparison, BIIB.SW has a market cap of 21.6B. Regarding current trading prices, BMY.SW is priced at CHF 42.54, while BIIB.SW trades at CHF 147.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BMY.SW currently has a P/E ratio of 15.81, whereas BIIB.SW's P/E ratio is 21.69. In terms of profitability, BMY.SW's ROE is +0.37%, compared to BIIB.SW's ROE of +0.07%. Regarding short-term risk, BMY.SW and BIIB.SW have similar daily volatility (0.00).Check BIIB.SW's competition here

Bristol-Myers Squibb Company